Reply to thread

Message: <blockquote data-quote="imhotep" data-source="post: 29496327" data-attributes="member: 562115">Using a new technology developed at MIT, diagnosing lung cancer could become as easy as inhaling nanoparticle sensors and then taking a urine test that reveals whether a tumor is present.The new diagnostic is based on nanosensors that can be delivered by an inhaler or a nebulizer. If the sensors encounter cancer-linked proteins in the lungs, they produce a signal that accumulates in the urine, where it can be detected with a simple paper test strip.This approach could potentially replace or supplement the current gold standard for diagnosing lung cancer, low-dose computed tomography (CT). It could have an especially significant impact in low- and middle-income countries that don't have widespread availability of CT scanners, the researchers say.These sensors consist of polymer nanoparticles coated with a reporter, such as a DNA barcode, that is cleaved from the particle when the sensor encounters enzymes called proteases, which are often overactive in tumors. Those reporters eventually accumulate in the urine and are excreted from the body.Previous versions of the sensors, which targeted other cancer sites such as the liver and ovaries, were designed to be given intravenously. For lung cancer diagnosis, the researchers wanted to create a version that could be inhaled, which could make it easier to deploy in lower resource settings.Also Phase I trials for a similar sensor for use in diagnosing liver cancer and a form of hepatitis known as nonalcoholic steatohepatitis (NASH) is already on the way.</blockquote>

Verification: Hath warak paha keeyada? (hatha wadikireema paha)

Top Bottom